Digital transformation key to managing rising organisational healthcare costs in India
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Prateek has more than 23 years of rich experience in Human Resource
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The companies will work with investigators to share the results with the scientific community
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
 
        Subscribe To Our Newsletter & Stay Updated